Neural Conduction Along the Visual Pathways After Oral Treatment With Citicoline in Patients With Optic Nerve Diseases

NCT00404729 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Glaucoma
Optic Neuropathy, Ischemic
Visual Pathway Disorder
Optic Nerve
Neural Conduction

Interventions

DRUG: Citicoline

Sponsor

Fondazione G.B. Bietti, IRCCS